Skip to content

Investor Overview

We are a global specialty and branded pharmaceutical company, improving the health of patients across the world through our high quality and affordable products. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability, positioning us well to maximise the value we create for our business and our diverse stakeholders.

We supply medicines to more than 150 countries and have 69 established business offices in more than 50 countries. We focus on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets.

FAST FACTS

OUR INVESTMENT CASE

Our vision inspires our actions
To deliver value to our stakeholders as a responsible corporate citizen that provides high quality, affordable medicines globally.

 

Global footprint with weighting towards emerging markets

Commercial and sales employees:

2 088
in emerging countries

304


in developed countries

Medicines supplied to more than
130 emerging and over 25 developed
countries

Strategically relevant manufacturing capital
Responsible corporate citizen and trusted partner
Diverse product portfolio with strong brand equity
Committed management team, strongly aligned with shareholders’ interests

Gross profit by business segment (%)

pg47-graph2

SENS ANNOUNCEMENTS

SHARE PRICE CENTRE

View share price information for Aspen Holdings.

SHARE CODE

APN ISIN: ZAE 000066692

JSE data delayed by 15 minutes, page refreshes every 5 minutes. Indicated trade times are actual.

PRESENTATIONS

Annual Results Presentation for the year ended 30 June 2021

 

CAPITAL
DISTRIBUTIONS

All capital distributions to date

SHAREHOLDER
STATISTICS

Analysis of shareholders at 30 June 2019

CORPORATE INFORMATION

All corporate information and contact details

REGISTER FOR ALERTS

CONTACT DETAILS

Investor Relations
+27 31 580 8600
InvestorRelations@aspenpharma.com

WEBCASTS

Click to view the webcast recording
of our Financial Results for
the year ended 30 June 2021

Click here to view our
Investor Day webcast of
11 December 2020

INVESTOR CALENDAR

09
March 2022
Interim results SENS announcement

10
March 2022
Interim results presentation

15
March 2022
JP Morgan South African Healthcare Seminar (virtual)

29
March 2022
Bank of America Securities 23rd Annual Sun City Conference (virtual)

31
August 2022
Annual results SENS announcement

01
September 2022
Annual results presentation

12
September 2022
13th Annual RMB Morgan Stanley Big Five Investor Conference

08
December 2022
Annual General Meeting

Scroll To Top